Showing results (91-100 of 384) with videos related to
Sort By:
Pageof 39
Future Oncology (London, England)|May 12, 2018
Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labelingPeter Reichardt, Marie-Dominique Tabone, Jaume Mora, et al.Rare Tumors|May 2, 2017
Myoepithelial Carcinoma of the Paracecal Mesentery: Aggressive Behavior of a Rare Neoplasm at an Unusual Anatomic SiteKhin Thway, Jonathan Noujaim, D Michael Thomas, et al.Marine Drugs|February 17, 2015
Trabectedin in soft tissue sarcomasBradley J Petek, Elizabeth T Loggers, Seth M Pollack, et al.European Journal of Cancer (Oxford, England : 1990)|September 22, 2009
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosisAnastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Olaratumab in soft tissue sarcoma - Current status and future perspectivesGeorgios Antoniou, Alexander T J Lee, Paul H Huang, et al.International Journal of Surgical Pathology|July 4, 2020
<i>EWSR1-SMAD3</i>-Positive Fibroblastic TumorOliver Foot, Magnus Hallin, Robin L Jones, et al.Critical Reviews in Oncology/Hematology|March 9, 2023
The biology and treatment of leiomyosarcomasWilliam G J Kerrison, Khin Thway, Robin L Jones, et al.Cancer Management and Research|June 23, 2023
Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing SarcomaAntonia Digklia, Ana Dolcan, Monika A Kucharczyk, et al.Cancers|November 13, 2020
Optimal Clinical Management and the Molecular Biology of AngiosarcomasTom Wei-Wu Chen, Jessica Burns, Robin L Jones, et al.Current Opinion in Oncology|June 17, 2020
Tropomyosin receptor kinase inhibitors in the management of sarcomasChristopher P Wilding, Herbert H Loong, Paul H Huang, et al.Pageof 39